Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.79 USD | -3.66% | -7.26% | -10.85% |
May. 20 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
May. 06 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.85% | 333M | |
+18.39% | 125B | |
+13.58% | 108B | |
-7.26% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.23% | 16.37B | |
+1.38% | 13.58B | |
+27.54% | 11.66B |
- Stock Market
- Equities
- FHTX Stock
- News Foghorn Therapeutics Inc.
- Morgan Stanley Adjusts Price Target on Foghorn Therapeutics to $6 From $10, Maintains Equalweight Rating